48,830
edits
Difference between revisions of "Celiac sprue"
Jump to navigation
Jump to search
→Clinical
m |
|||
| Line 30: | Line 30: | ||
===Serologic testing=== | ===Serologic testing=== | ||
*Anti-tissue transglutaminase (TTG) antibody | *Anti-tissue transglutaminase (TTG) antibody -- >10 U/mL considered positive.<ref>URL: [http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/82587 http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/82587]. Accessed on: 13 August 2012.</ref> | ||
**Alternative test: anti-endomysial antibody. | **Alternative test: anti-endomysial antibody. | ||
*Anti-gliadin antibodies.<ref name=pmid19629760>{{Cite journal | last1 = Matthias | first1 = T. | last2 = Pfeiffer | first2 = S. | last3 = Selmi | first3 = C. | last4 = Eric Gershwin | first4 = M. | title = Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. | journal = Clin Rev Allergy Immunol | volume = 38 | issue = 2-3 | pages = 298-301 | month = Apr | year = 2010 | doi = 10.1007/s12016-009-8160-z | PMID = 19629760 }}</ref> | *Anti-gliadin antibodies.<ref name=pmid19629760>{{Cite journal | last1 = Matthias | first1 = T. | last2 = Pfeiffer | first2 = S. | last3 = Selmi | first3 = C. | last4 = Eric Gershwin | first4 = M. | title = Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. | journal = Clin Rev Allergy Immunol | volume = 38 | issue = 2-3 | pages = 298-301 | month = Apr | year = 2010 | doi = 10.1007/s12016-009-8160-z | PMID = 19629760 }}</ref> | ||